Anticipatory Medicines in Dementia End of Life Care: Storage, Administration, Records and Out-of-Hours Safety

February 25, 2026

Anticipatory medicines can prevent avoidable distress in dementia end of life care, but only when they are governed as a real operational system: authorisation routes, storage controls, competent administration, reliable records and predictable out-of-hours escalation. This article sits within dementia end-of-life and advance care planning guidance and should be read alongside dementia service models and operational delivery, because medicines safety depends on how your rota, on-call and clinical links actually work day to day. The aim is simple: reduce crisis transfers and unmanaged symptoms by making anticipatory medicines safe, timely and evidenced rather than assumed.

What commissioners and inspectors are looking for

Anticipatory medicines are often mentioned in tenders and service specs, but the scoring and scrutiny focus on whether you can run them safely at 02:00 on a bank holiday. Strong answers (and strong practice) show that you have clear authority to administer, staff who are trained and assessed, controlled storage, and documentation that allows another professional to understand exactly what happened and why.

Commissioner expectation (explicit)

Commissioners expect a reliable out-of-hours pathway that prevents avoidable 999 calls and hospital conveyance. That means you can evidence: who is called first, how quickly advice is obtained, what is recorded, and how learning is fed back into the care plan and wider governance.

Regulator / inspector expectation (explicit)

CQC inspectors expect medicines to be safe, person-centred and well-led: clear policies translated into practice, staff competence evidenced, errors learned from, and records that demonstrate the right medicine was given for the right reason with the right authorisation and follow-up.

Define anticipatory medicines in dementia end of life care

Anticipatory medicines are prescribed in advance so symptoms such as pain, breathlessness, agitation, nausea or respiratory secretions can be managed promptly when a person deteriorates. In dementia, additional complexity is common: fluctuating capacity, communication barriers, delirium, swallowing risk, and distress that can be misread as “behaviour” rather than unmet need. Your approach should therefore connect medicines to a broader comfort plan: observation routines, non-pharmacological support, family communication, and escalation to clinical professionals.

Authorisation and administration: remove the grey areas

Many services come unstuck because the boundary between prompting, assisting and administering is unclear, especially for PRN medicines. A safe system makes the authorisation route explicit and trains staff to work within it.

Who can administer: identify roles and competency levels (e.g., trained care staff under a delegated task arrangement, registered nurses, or hospice/community nursing input).
When administration is permitted: link to the prescription directions, symptom triggers, and any agreed clinical guidance in the care plan.
When to stop and escalate: red flags (e.g., new severe pain, respiratory compromise, suspected infection, reduced consciousness, repeated PRN doses with limited effect).

Make it practical: “Staff do X, then Y, then call Z within N minutes.” Avoid policy-only wording.

Storage and access: build controls that still work under pressure

Anticipatory medicines must be accessible quickly, but access must be controlled. A workable approach usually includes:

Secure storage in the person’s home or setting (locked cabinet or equivalent), with a clear key/control process.
Receipt and stock check process when medicines arrive: what was delivered, quantities, expiry dates, and where stored.
Shift-to-shift checks proportionate to risk: daily check for high-risk items, weekly full reconciliation where appropriate.
Temperature and environment checks where required, and a process for reporting concerns (heat, damp, unsafe location).

Critically, your system should define what happens when storage isn’t safe (e.g., repeated missing keys, family conflict, suspected diversion). A high-scoring approach shows you can protect the person and the medicines without delaying care.

Operational Example 1: Rapid symptom control without losing governance

Context: A person with advanced dementia becomes increasingly restless and distressed overnight, pulling at clothing and resisting personal care. Family are frightened and ask for an ambulance.

Support approach: The night team uses the comfort plan first: low-stimulation environment, familiar music, repositioning, mouth care, and reassurance. They complete a short symptom check (pain cues, breathing, temperature, urine output concerns) and refer to the anticipatory medicines guidance in the care plan.

Day-to-day delivery detail: The senior on shift calls the on-call lead within 10 minutes and documents the trigger, observations and what has already been tried. The on-call lead contacts the agreed clinical advice line (community nursing/hospice/OOH GP route depending on locality) and confirms whether the PRN medicine can be administered, at what dose, and what monitoring is required. The administering staff member follows the MAR instructions, records the route, dose, time, symptom trigger and immediate effect, and repeats observations at agreed intervals.

How effectiveness is evidenced: The following morning the Registered Manager reviews the record, confirms the authorisation route was followed, and logs the episode for monthly medicines sampling. The care plan is updated to reflect what worked, and the family receives a clear summary of the actions taken and the escalation pathway used.

Competence and supervision: prove skill, not intention

In end of life care, competence is more than “training completed”. Your evidence should show:

Initial training: symptom recognition in dementia, PRN decision logic, medicine routes, and documentation standards.
Observed practice: supervised administration (where role-appropriate), scenario-based checks, and sign-off criteria.
Refreshers and learning: quarterly short updates tied to incident themes and audit findings.
Supervision focus: reflective discussion on a recent comfort episode, what was escalated, and what could be improved.

This is also where services strengthen tender responses: describing how competence is checked, not just delivered.

Out-of-hours safety: build a pathway that is fast and documented

Most avoidable failures happen out of hours: unclear contacts, delayed advice, missing information, or inconsistent decisions across shifts. A strong pathway includes:

Single escalation card available in the care plan: contacts, order of calls, expected response times, and what information to provide.
Minimum dataset to share: baseline condition, DNACPR/ReSPECT status if in place, current symptoms, recent PRN use, allergies, and current medicines list.
Decision record that captures who advised what, and what monitoring or follow-up was agreed.
Next-day review to confirm plan updates and learning.

Operational Example 2: Controlled storage when family dynamics increase risk

Context: A family member insists on holding the key to the medicines cabinet and becomes angry when staff request access to complete checks. Staff are concerned about missing doses and possible diversion.

Support approach: The Registered Manager meets the family, explains the shared aim (comfort and safety), and sets out the minimum storage and access requirements. The service agrees a practical compromise: a dual-key process where the family holds one key and the service holds the other, with planned check times and an escalation route if access is denied.

Day-to-day delivery detail: Staff document each access event, record any refusals, and escalate same-day to the on-call lead. If access is blocked and symptom control is at risk, the service triggers the agreed clinical escalation and informs the relevant professional (e.g., community nurse/hospice) to review the plan and risks.

How effectiveness is evidenced: The service completes a weekly reconciliation for four weeks, records outcomes (no missing stock, improved cooperation), and logs the case as a safeguarding/medicines governance learning item, updating guidance for future similar situations.

Records and MAR standards: write it so another clinician can trust it

End of life care records need to be readable under pressure and defensible later. Your documentation should show:

Symptom trigger: what was observed and how it was interpreted (especially where the person cannot describe pain).
Authorisation: what authority was relied on (prescription directions, delegated task protocol, clinical advice) and who gave advice if applicable.
Medicine details: name, dose, route, time, and any batch/controlled record requirements.
Effect and monitoring: what changed, what didn’t, and what follow-up was agreed.
Family communication: what was explained and any questions answered.

Where digital records are used, explain how you prevent missing fields, how you manage connectivity issues, and how audit trails are accessed in governance reviews.

Operational Example 3: PRN drift prevention through audit and feedback

Context: A service notices PRN medicines are being used more frequently for distress in a small number of people with dementia, and staff are beginning to rely on PRN before trying comfort measures.

Support approach: The service introduces a “comfort first” prompt in the care notes: staff must record at least two non-pharmacological actions attempted (where appropriate) before PRN, unless there is an immediate clinical indication. The clinical lead reviews cases weekly for four weeks.

Day-to-day delivery detail: Shift leaders discuss PRN use at handover using a short checklist: trigger, what was tried, effect, and whether escalation is needed. Staff receive micro-coaching in recognising pain cues in dementia and differentiating agitation from unmet physical needs.

How effectiveness is evidenced: Monthly medicines audits track PRN frequency, reasons, and effect. The service reports a reduction in PRN episodes linked to “unexplained agitation” and an increase in documented comfort measures, with a governance note confirming the approach is embedded and reviewed quarterly.

Governance and assurance: make improvement measurable

To show maturity (and to satisfy scrutiny), your governance loop should include:

Sampling: monthly review of a defined number of end of life medicines records and MAR entries.
Trend reporting: themes such as delayed escalation, missing authorisation notes, repeated PRN with limited effect, or storage issues.
Action tracking: named owners, deadlines, and re-check dates.
Interface with safeguarding: clear triggers for safeguarding concerns (neglect, diversion, coercion, family conflict impacting care).

In tender writing terms, this is the difference between “we have policies” and “we can prove the system works and improves”.

Common pitfalls that lose points (and how to fix them)

Vague authority: fix by stating explicit administration routes and escalation thresholds.
Storage described but not controlled: fix by adding key control, reconciliation, and what happens when access is blocked.
Records that don’t evidence decision-making: fix by requiring symptom trigger, authorisation and effect fields as a minimum.
Out-of-hours not operationalised: fix by adding the escalation card, minimum dataset, and next-day review.

If your anticipatory medicines approach is safe, timely and documented, it reduces distress, prevents crisis transfers and builds confidence with families and professionals. The strongest services treat it as a governed pathway, not a medication list.